Melasma is an acquired hypermelanosis characterized by a symmetrical macular pigmentation of sun-exposed areas like the face. Tranexamic acid is commonly being used to reduce melanin synthesis in patients with melasma and also used as a raw material for functional whitening cosmetics. The aim of this work is to Assess efficacy of Tranexamic acid in the treatment of melasma. This study was conducted in Dermatology, STDS and Andrology Department of Fayoum
Introduction
Melasma is a common acquired pigmentary skin disorder characterized by a symmetrical macular pigmentation of sun-exposed areas like 3. This study revealed that there was significant difference with p-value <0.05 in mMASI score before and after treatment between different types of melasma with high difference between mean of mMASI score before and after treatment among dermal type of melasma 4.When studying the Correlation between mMASI score in relation to age and Disease duration There was statistically significant positive correlation with p-value <0.05 between m MASI score before and after treatment with age and duration of disease, which indicated that increasing in age and disease duration was associated with increasing in mMASI score before and after treatment In this study there was significant difference with p-value <0.05 in mMASI score before and after treatment between different types of melasma with high difference between mean of mMASI score before and after treatment among dermal type of melasma. This indicates that both procedures may improve dermal type of melasma which is always difficult to treat as it is out of rich to topical drugs. So that combinations of these procedures with traditional treatments of melasma may give promising results.
Conclusion
In our study we concluded that: Our findings suggest that TA can play a role in melasma treatment. *TA intradermal injection or topical TA with laser assisted technique can be used as potentially a safe and effective therapeutic agent for treatment of melasma.
*Both methods can be effective in treatment of dermal type which is always difficult in treatment.
*Both intradermal injection TA and fractional CO 2 assisted drug delivery had nearly the same effect on melisma.
In this study there was significant difference with p-value <0.05 in mMASI score before and after treatment between different types of melasma with high difference between mean of mMASI score before and after treatment among dermal type of melasma. This indicates that both procedures may improve dermal type of melasma which is always difficult to treat as it is out of rich to topical drugs. So that combinations of these procedures with traditional treatments of melasma may give promising results. ISSN: 2536-9474 (Print) Original article / FYMJ ISSN: 2536-9482 (Online) Fayoum University Medical Journal A. El-Fatah et al., 2019,3(2), 36-46 Page 101
In our study we concluded that:
Our findings suggest that TA can play a role in melasma treatment. A review of laser and light therapy in melasma.
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